Illustration: Sarah Grillo/Axios
Court Square Capital and WindRose Health agreed to pay $1.1 billion to acquire infusion company Soleo Health from H.I.G. Capital, sources familiar tell Axios.
Why it matters: Sponsors continue to pay premium prices for ambulatory infusion assets.
